← Eichor
Condition: Granulocyte Colony Stimulating Factor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Granulocyte Colony Stimulating Factor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Phase 3 · 4 location(s) · Center for International Blood and Marrow Transplant Researc · NCT00785525Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
NA · 1 location(s) · National Liver Institute, Egypt · NCT06708572Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
Phase 2 · 1 location(s) · Fakih IVF Fertility Center · NCT07724405CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NA · 3 location(s) · First Affiliated Hospital of Zhejiang University · NCT07423728Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
NA · 1 location(s) · Yang Xiaotian · NCT06536010Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Phase N/A · 1 location(s) · Northwell Health · NCT07186179Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilizat
EARLY_Phase 1 · 2 location(s) · Rutgers, The State University of New Jersey · NCT04211259OH2 Oncolytic Viral Therapy in Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT03866525CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT04050280A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combine
Phase 2 · 2 location(s) · Franziska Wachter · NCT05796570Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
NA · 1 location(s) · Alexandria University · NCT07300735Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standar
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07002827Improving White Blood Cell Collection From Healthy Donors
Phase 4 · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT01553214Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Pati
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT00801489A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After
Phase 1 · 8 location(s) · National Cancer Institute (NCI) · NCT07012044Loratadine for the Prevention of G-CSF-related Bone Pain
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05421416RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
EARLY_Phase 1 · 1 location(s) · Yana Najjar · NCT06216938Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Phase 2 · 1 location(s) · Zhongnan Hospital · NCT05817214Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
Phase N/A · 1 location(s) · Izmir Katip Celebi University · NCT06961409Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06926751Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001529Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT05753618G-CSF After Chemo-radiation in Patients With Glioblastoma
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06649851Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosi
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01624805Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
Phase 3 · 8 location(s) · First Affiliated Hospital of Zhejiang University · NCT07692841
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.